HEADER SIGNALING PROTEIN 16-JAN-06 2FPD TITLE SAD STRUCTURE DETERMINATION: CRYSTAL STRUCTURE OF THE INTRINSIC TITLE 2 DIMERIZATION SH3 DOMAIN OF THE IB1 SCAFFOLD PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: C-JUN-AMINO-TERMINAL KINASE INTERACTING PROTEIN 1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: SH3 DOMAIN, RESIDUES 1-60; COMPND 5 SYNONYM: JNK-INTERACTING PROTEIN 1, JIP-1, JNK MAP KINASE SCAFFOLD COMPND 6 PROTEIN 1, ISLET-BRAIN-1, IB-1, MITOGEN-ACTIVATED PROTEIN KINASE 8- COMPND 7 INTERACTING PROTEIN 1, JIP-1-RELATED PROTEIN, JRP; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: MAPK8IP1, IB1, JIP1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX 4T-1 KEYWDS SRC-HOMOLOGY 3 (SH3) DOMAIN, ALL BETA STRUCTURE, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR O.KRISTENSEN,I.DAR,M.GAJHEDE REVDAT 5 29-JUL-20 2FPD 1 COMPND REMARK SEQADV HET REVDAT 5 2 1 HETNAM HETSYN FORMUL LINK REVDAT 5 3 1 SITE ATOM REVDAT 4 23-MAY-18 2FPD 1 REMARK REVDAT 3 24-FEB-09 2FPD 1 VERSN REVDAT 2 07-MAR-06 2FPD 1 JRNL REVDAT 1 28-FEB-06 2FPD 0 JRNL AUTH O.KRISTENSEN,S.GUENAT,I.DAR,N.ALLAMAN-PILLET,A.ABDERRAHMANI, JRNL AUTH 2 M.FERDAOUSSI,R.RODUIT,F.MAURER,J.S.BECKMANN,J.S.KASTRUP, JRNL AUTH 3 M.GAJHEDE,C.BONNY JRNL TITL A UNIQUE SET OF SH3-SH3 INTERACTIONS CONTROLS IB1 JRNL TITL 2 HOMODIMERIZATION JRNL REF EMBO J. V. 25 785 2006 JRNL REFN ISSN 0261-4189 JRNL PMID 16456539 JRNL DOI 10.1038/SJ.EMBOJ.7600982 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.DICKENS,J.S.ROGERS,J.CAVANAGH,A.RAITANO,Z.XIA,J.R.HALPERN, REMARK 1 AUTH 2 M.E.GREENBERG,C.L.SAWYERS,R.J.DAVIS REMARK 1 TITL A CYTOPLASMIC INHIBITOR OF THE JNK SIGNAL TRANSDUCTION REMARK 1 TITL 2 PATHWAY REMARK 1 REF SCIENCE V. 277 693 1997 REMARK 1 REFN ISSN 0036-8075 REMARK 1 PMID 9235893 REMARK 1 DOI 10.1126/SCIENCE.277.5326.693 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.BONNY,P.NICOD,G.WAEBER REMARK 1 TITL IB1, A JIP-1-RELATED NUCLEAR PROTEIN PRESENT IN REMARK 1 TITL 2 INSULIN-SECRETING CELLS REMARK 1 REF J.BIOL.CHEM. V. 273 1843 1998 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 9442013 REMARK 1 DOI 10.1074/JBC.273.4.1843 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.NIHALANI,H.N.WONG,L.B.HOLZMAN REMARK 1 TITL RECRUITMENT OF JNK TO JIP1 AND JNK-DEPENDENT JIP1 REMARK 1 TITL 2 PHOSPHORYLATION REGULATES JNK MODULE DYNAMICS AND ACTIVATION REMARK 1 REF J.BIOL.CHEM. V. 278 28694 2003 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 12756254 REMARK 1 DOI 10.1074/JBC.M304212200 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.YASUDA,A.J.WHITMARSH,J.CAVANAGH,M.SHARMA,R.J.DAVIS REMARK 1 TITL THE JIP GROUP OF MITOGEN-ACTIVATED PROTEIN KINASE SCAFFOLD REMARK 1 TITL 2 PROTEINS REMARK 1 REF MOL.CELL.BIOL. V. 19 7245 1999 REMARK 1 REFN ISSN 0270-7306 REMARK 1 PMID 10490659 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1632143.920 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 37925 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1947 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5051 REMARK 3 BIN R VALUE (WORKING SET) : 0.1910 REMARK 3 BIN FREE R VALUE : 0.2480 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 303 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2080 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 249 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.98000 REMARK 3 B22 (A**2) : 0.82000 REMARK 3 B33 (A**2) : -1.80000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.12 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.710 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.42 REMARK 3 BSOL : 49.59 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : TRE_XPLOR_PARAM.TXT REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : TRE_XPLOR_TOP.TXT REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: EXPERIMENTAL PHASES WERE USED REMARK 3 THROUGHOUT IN THE REFINEMENT, WHICH WAS BASED ON THE MLHL TARGET REMARK 3 FUNCTION. REMARK 4 REMARK 4 2FPD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000036148. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-SEP-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 9.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I711 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.967 REMARK 200 MONOCHROMATOR : BENDABLE ASYMMETRICALLY CUT REMARK 200 SI(111) CRYSTAL IN COMBINATION REMARK 200 WITH VERTICALLY FOCUSING MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37925 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 8.020 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : 0.09600 REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : 8.24 REMARK 200 R MERGE FOR SHELL (I) : 0.34000 REMARK 200 R SYM FOR SHELL (I) : 0.34000 REMARK 200 FOR SHELL : 2.280 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE, SHARP, CCP4 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, BICINE, PH 9.00, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 57.24300 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 57.24300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 24.21000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 57.24300 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 57.24300 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 24.21000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 57.24300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 57.24300 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 24.21000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 57.24300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 57.24300 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 24.21000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 14220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -105.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 23 0.91 82.95 REMARK 500 ASP B 23 -2.67 82.08 REMARK 500 SER C 0 12.91 -146.36 REMARK 500 GLN D 31 -153.80 -74.95 REMARK 500 ALA D 32 -67.49 -137.82 REMARK 500 GLU D 33 -40.24 69.36 REMARK 500 THR D 59 144.42 -26.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FPE RELATED DB: PDB REMARK 900 DIFFERENT CRYSTAL FORM OF THE SAME PROTEIN REMARK 900 RELATED ID: 2FPF RELATED DB: PDB REMARK 900 LONGER VARIANT OF THE SAME PROTEIN DBREF 2FPD A 1 60 UNP Q9R237 JIP1_RAT 487 546 DBREF 2FPD B 1 60 UNP Q9R237 JIP1_RAT 487 546 DBREF 2FPD C 1 60 UNP Q9R237 JIP1_RAT 487 546 DBREF 2FPD D 1 60 UNP Q9R237 JIP1_RAT 487 546 SEQADV 2FPD GLY A -1 UNP Q9R237 CLONING ARTIFACT SEQADV 2FPD SER A 0 UNP Q9R237 CLONING ARTIFACT SEQADV 2FPD MSE A 42 UNP Q9R237 MET 528 MODIFIED RESIDUE SEQADV 2FPD GLY B -1 UNP Q9R237 CLONING ARTIFACT SEQADV 2FPD SER B 0 UNP Q9R237 CLONING ARTIFACT SEQADV 2FPD MSE B 42 UNP Q9R237 MET 528 MODIFIED RESIDUE SEQADV 2FPD GLY C -1 UNP Q9R237 CLONING ARTIFACT SEQADV 2FPD SER C 0 UNP Q9R237 CLONING ARTIFACT SEQADV 2FPD MSE C 42 UNP Q9R237 MET 528 MODIFIED RESIDUE SEQADV 2FPD GLY D -1 UNP Q9R237 CLONING ARTIFACT SEQADV 2FPD SER D 0 UNP Q9R237 CLONING ARTIFACT SEQADV 2FPD MSE D 42 UNP Q9R237 MET 528 MODIFIED RESIDUE SEQRES 1 A 62 GLY SER GLU GLN THR HIS ARG ALA ILE PHE ARG PHE VAL SEQRES 2 A 62 PRO ARG HIS GLU ASP GLU LEU GLU LEU GLU VAL ASP ASP SEQRES 3 A 62 PRO LEU LEU VAL GLU LEU GLN ALA GLU ASP TYR TRP TYR SEQRES 4 A 62 GLU ALA TYR ASN MSE ARG THR GLY ALA ARG GLY VAL PHE SEQRES 5 A 62 PRO ALA TYR TYR ALA ILE GLU VAL THR LYS SEQRES 1 B 62 GLY SER GLU GLN THR HIS ARG ALA ILE PHE ARG PHE VAL SEQRES 2 B 62 PRO ARG HIS GLU ASP GLU LEU GLU LEU GLU VAL ASP ASP SEQRES 3 B 62 PRO LEU LEU VAL GLU LEU GLN ALA GLU ASP TYR TRP TYR SEQRES 4 B 62 GLU ALA TYR ASN MSE ARG THR GLY ALA ARG GLY VAL PHE SEQRES 5 B 62 PRO ALA TYR TYR ALA ILE GLU VAL THR LYS SEQRES 1 C 62 GLY SER GLU GLN THR HIS ARG ALA ILE PHE ARG PHE VAL SEQRES 2 C 62 PRO ARG HIS GLU ASP GLU LEU GLU LEU GLU VAL ASP ASP SEQRES 3 C 62 PRO LEU LEU VAL GLU LEU GLN ALA GLU ASP TYR TRP TYR SEQRES 4 C 62 GLU ALA TYR ASN MSE ARG THR GLY ALA ARG GLY VAL PHE SEQRES 5 C 62 PRO ALA TYR TYR ALA ILE GLU VAL THR LYS SEQRES 1 D 62 GLY SER GLU GLN THR HIS ARG ALA ILE PHE ARG PHE VAL SEQRES 2 D 62 PRO ARG HIS GLU ASP GLU LEU GLU LEU GLU VAL ASP ASP SEQRES 3 D 62 PRO LEU LEU VAL GLU LEU GLN ALA GLU ASP TYR TRP TYR SEQRES 4 D 62 GLU ALA TYR ASN MSE ARG THR GLY ALA ARG GLY VAL PHE SEQRES 5 D 62 PRO ALA TYR TYR ALA ILE GLU VAL THR LYS MODRES 2FPD MSE A 42 MET SELENOMETHIONINE MODRES 2FPD MSE B 42 MET SELENOMETHIONINE MODRES 2FPD MSE C 42 MET SELENOMETHIONINE MODRES 2FPD MSE D 42 MET SELENOMETHIONINE HET MSE A 42 8 HET MSE B 42 8 HET MSE C 42 8 HET MSE D 42 8 HET GLC E 1 11 HET GLC E 2 12 HET SO4 C1003 5 HET SO4 D1002 5 HETNAM MSE SELENOMETHIONINE HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM SO4 SULFATE ION FORMUL 1 MSE 4(C5 H11 N O2 SE) FORMUL 5 GLC 2(C6 H12 O6) FORMUL 6 SO4 2(O4 S 2-) FORMUL 8 HOH *249(H2 O) SHEET 1 A 5 ARG A 47 PRO A 51 0 SHEET 2 A 5 TRP A 36 ASN A 41 -1 N ALA A 39 O GLY A 48 SHEET 3 A 5 PRO A 25 GLN A 31 -1 N LEU A 30 O GLU A 38 SHEET 4 A 5 HIS A 4 ALA A 6 -1 N HIS A 4 O LEU A 26 SHEET 5 A 5 ALA A 55 GLU A 57 -1 O ILE A 56 N ARG A 5 SHEET 1 B 5 ARG B 47 PRO B 51 0 SHEET 2 B 5 TRP B 36 ASN B 41 -1 N ALA B 39 O GLY B 48 SHEET 3 B 5 PRO B 25 GLN B 31 -1 N LEU B 30 O GLU B 38 SHEET 4 B 5 HIS B 4 ALA B 6 -1 N HIS B 4 O LEU B 26 SHEET 5 B 5 ALA B 55 GLU B 57 -1 O ILE B 56 N ARG B 5 SHEET 1 C 5 ARG C 47 PRO C 51 0 SHEET 2 C 5 TRP C 36 ASN C 41 -1 N ALA C 39 O GLY C 48 SHEET 3 C 5 PRO C 25 GLN C 31 -1 N LEU C 30 O GLU C 38 SHEET 4 C 5 HIS C 4 ALA C 6 -1 N HIS C 4 O LEU C 26 SHEET 5 C 5 ALA C 55 GLU C 57 -1 O ILE C 56 N ARG C 5 SHEET 1 D 5 ARG D 47 PRO D 51 0 SHEET 2 D 5 TRP D 36 ASN D 41 -1 N ALA D 39 O GLY D 48 SHEET 3 D 5 PRO D 25 VAL D 28 -1 N LEU D 27 O TYR D 40 SHEET 4 D 5 HIS D 4 ALA D 6 -1 N HIS D 4 O LEU D 26 SHEET 5 D 5 ALA D 55 GLU D 57 -1 O ILE D 56 N ARG D 5 LINK C ASN A 41 N MSE A 42 1555 1555 1.33 LINK C MSE A 42 N ARG A 43 1555 1555 1.33 LINK C ASN B 41 N MSE B 42 1555 1555 1.33 LINK C MSE B 42 N ARG B 43 1555 1555 1.33 LINK C ASN C 41 N MSE C 42 1555 1555 1.33 LINK C MSE C 42 N ARG C 43 1555 1555 1.33 LINK C ASN D 41 N MSE D 42 1555 1555 1.33 LINK C MSE D 42 N ARG D 43 1555 1555 1.33 LINK C1 GLC E 1 O1 GLC E 2 1555 1555 1.40 CRYST1 114.486 114.486 48.420 90.00 90.00 90.00 P 42 21 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008735 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008735 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020653 0.00000